GSK licenses Aurobindo, Cipla and Viatris to make generic versions of injectable cabotegravir
British drugmaker GSK has signed deals with three companies allowing them to make inexpensive generic versions of its long-acting HIV preventive medicine for use in...
INSIGHT: Generics shortages could get way worse across Europe
When Ignasi Biosca-Reig heard there were generics shortages of amoxicillin in Spain, he quickly added shifts at his drug company's factories to boost production...
Operating profit set to grow as Novartis prepares to spin off its Sandoz generics business
Novartis on Wednesday (February 1) predicted that core operating income would grow in a "mid single digit" percentage range in 2023 following stagnation last year,...